Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma. Issue 1 (October 2015)
- Record Type:
- Journal Article
- Title:
- Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma. Issue 1 (October 2015)
- Main Title:
- Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma
- Authors:
- Nesteruk, Marta
Lang, Stephanie
Veit-Haibach, Patrick
Studer, Gabriela
Stieb, Sonja
Glatz, Stefan
Hemmatazad, Hossein
Ikenberg, Kristian
Huber, Gerhard
Pruschy, Martin
Guckenberger, Matthias
Klöck, Stephan
Riesterer, Oliver - Abstract:
- <abstract xml:lang="en" abstract-type="author" id="ab005"> <title id="st005">Abstract</title> <sec> <title id="st010">Background and purpose</title> <p id="sp0005">This study investigated whether tumor perfusion, FDG uptake and their correlation depend on tumor stage, site and HPV in head and neck cancer.</p> </sec> <sec> <title id="st015">Material and methods</title> <p id="sp0010">41/55 eligible patients with integrated FDG-PET/perfusion CT from 2 prospective studies were assessed. A GTV<sup>CT</sup> and GTV<sup>PET</sup> were created. Perfusion maps were calculated using singular value decomposition method. Blood volume (BV), blood flow (BF), mean transit time (MTT) and standardized uptake value (SUV) in the tumor were compared to the surrounding tissue using Wilcoxon test and Spearman correlation of perfusion and SUV<sub>mean</sub> in the tumor was studied (<italic>p</italic> = 0.05).</p> </sec> <sec> <title id="st020">Results</title> <p id="sp0015">Perfusion parameters were significantly increased in the GTV<sup>CT</sup> of advanced tumors in comparison to the surrounding soft tissue (<italic>p</italic> &lt; 0.01). Oral cavity and oropharyngeal cancer showed a higher BF than laryngeal cancer (<italic>p</italic> &lt; 0.04). No correlation between perfusion and SUV<sub>mean</sub> was found, however SUV<sub>mean</sub> correlated significantly with BF for the HPV-positive tumors (<italic>r</italic> = 0.86, <italic>p</italic> = 0.04) and with BV for the oropharyngeal cancer<abstract xml:lang="en" abstract-type="author" id="ab005"> <title id="st005">Abstract</title> <sec> <title id="st010">Background and purpose</title> <p id="sp0005">This study investigated whether tumor perfusion, FDG uptake and their correlation depend on tumor stage, site and HPV in head and neck cancer.</p> </sec> <sec> <title id="st015">Material and methods</title> <p id="sp0010">41/55 eligible patients with integrated FDG-PET/perfusion CT from 2 prospective studies were assessed. A GTV<sup>CT</sup> and GTV<sup>PET</sup> were created. Perfusion maps were calculated using singular value decomposition method. Blood volume (BV), blood flow (BF), mean transit time (MTT) and standardized uptake value (SUV) in the tumor were compared to the surrounding tissue using Wilcoxon test and Spearman correlation of perfusion and SUV<sub>mean</sub> in the tumor was studied (<italic>p</italic> = 0.05).</p> </sec> <sec> <title id="st020">Results</title> <p id="sp0015">Perfusion parameters were significantly increased in the GTV<sup>CT</sup> of advanced tumors in comparison to the surrounding soft tissue (<italic>p</italic> &lt; 0.01). Oral cavity and oropharyngeal cancer showed a higher BF than laryngeal cancer (<italic>p</italic> &lt; 0.04). No correlation between perfusion and SUV<sub>mean</sub> was found, however SUV<sub>mean</sub> correlated significantly with BF for the HPV-positive tumors (<italic>r</italic> = 0.86, <italic>p</italic> = 0.04) and with BV for the oropharyngeal cancer (<italic>r</italic> = 0.63, <italic>p</italic> = 0.05).</p> </sec> <sec> <title id="st025">Conclusion</title> <p id="sp0020">Tumor stage, site and HPV are associated with different perfusion or combined perfusion/SUV signatures. Further studies are needed to investigate if these signatures co-determine clinical outcome.</p> </sec> </abstract> … (more)
- Is Part Of:
- Radiotherapy and oncology. Volume 117:Issue 1(2015:Oct.)
- Journal:
- Radiotherapy and oncology
- Issue:
- Volume 117:Issue 1(2015:Oct.)
- Issue Display:
- Volume 117, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 117
- Issue:
- 1
- Issue Sort Value:
- 2015-0117-0001-0000
- Page Start:
- 125
- Page End:
- 131
- Publication Date:
- 2015-10
- Subjects:
- Oncology -- Periodicals
Radiotherapy -- Periodicals
Tumors -- Periodicals
Medical Oncology -- Periodicals
Neoplasms -- radiotherapy -- Periodicals
Radiotherapy -- Periodicals
Radiothérapie -- Périodiques
Cancérologie -- Périodiques
Tumeurs -- Périodiques
Electronic journals
616.9940642 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01678140 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01678140 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01678140 ↗
http://www.estro.org/ ↗
http://www.elsevier.com/journals ↗
http://www.journals.elsevier.com/radiotherapy-and-oncology/ ↗ - DOI:
- 10.1016/j.radonc.2015.09.026 ↗
- Languages:
- English
- ISSNs:
- 0167-8140
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7240.790000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4176.xml